Koninklijke Philips | PHG - Cash And Equivalent


Koninklijke Philips reported EUR1.91B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Abbott USD 8.52B 1.01B Dec/2025
Baxter International USD 1.97B 240M Dec/2025
Becton, Dickinson and Co. USD 740M 99M Dec/2025
Boston Scientific USD 1.96B 690M Dec/2025
Danaher USD 5.7B 1.09B Mar/2026
Demant DKK 1.33B 188M Dec/2025
Dexcom USD 917.7M 918M Dec/2025
Edwards Lifesciences USD 2.4B 538M Mar/2026
Fresenius EUR 1.23B 1.16B Jun/2025
General Electric Aerospace USD 10.98B 1.41B Mar/2026
Getinge SEK 2.96B 720M Dec/2024
Globus Medical USD 526.16M 154.39M Dec/2025
GN Store Nord DKK 767M 363M Sep/2025
Hitachi JPY 1.28T 412.69B Sep/2025
Idexx Laboratories USD 180.07M 28.1M Dec/2025
Insulet USD 716.1M 41.3M Dec/2025
Integra LifeSciences USD 235.05M 2.86M Dec/2025
Intuitive Surgical USD 7.98B 1.05B Mar/2026
J&J USD 21.69B 1.98B Mar/2026
Koninklijke Philips EUR 1.91B 90M Sep/2025
Masimo USD 312.3M 162.7M Sep/2025
Medtronic USD 1.15B 135M Dec/2025
Philips EUR 1.91B 90M Sep/2025
ResMed USD 1.42B 33.22M Dec/2025
Steris USD 423.7M 104.5M Dec/2025
Stryker USD 4.01B 755M Dec/2025
Teleflex USD 354M 100.3M Sep/2025
Terumo JPY 217.16B 12.86B Sep/2025
Zimmer Biomet Holdings USD 591.9M 700.8M Dec/2025